Please assess the completion status of the following clinical trial:

Trial Title: Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~- Patients who start rivaroxaban for VTE(pulmonary embolism, deep vein thrombosis) anticoagulation therapy.~Exclusion Criteria:~- Patients who are contraindicated based on the product label and have already received Xarelto treatment.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rivaroxaban (Xarelto, BAY59-7939) (Type: None): Rivaroxavban administration group

Based on this trial design, predict the completion outcome and termination type (if applicable).